Hints and tips:
Related Special Reports
Related Topics
...Five of the companies, including ArriVent Biopharma and Dianthus Therapeutics, informed investors that they were exploring alternative manufacturing options to WuXi....
...The combination of mice and machine learning is crucial to T-Therapeutics’ operation....
...Belfast-based CV6 Therapeutics announced on Thursday that the UK’s medicines regulator had granted approval for the trials to be held in Belfast, Glasgow, Newcastle and London in the first quarter of 2024...
...US biotech Viking Therapeutics’ shares more than doubled after trial data for the company’s weight-loss drug outperformed existing treatments from drugmakers Novo Nordisk and Eli Lilly....
A moment of freedom from our serious selves is both joyful and therapeutic
...Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200mn in an initial public offering as early as this summer, propelled by investor hype over anti-obesity...
Mental healthcare can be life-saving, but Abigail Shrier argues that most therapeutic approaches have serious side effects and few benefits
...According to preliminary data, it cut body weight by 14.5 per cent after 12 weeks, a similar result to the weekly injection being trialled by Viking Therapeutics....
...The pharmaceutical group’s multi-part bond sale, which spanned maturities from two to 40 years, comes after it announced in late December that it would buy Karuna Therapeutics, a drugmaker that specialises...
...With foresight, 23andMe created a therapeutics research division nine years ago to exploit its extraordinary cache of genetic data....
...BMS plans to use some of the cash to finance its purchases of Karuna Therapeutics, a psychiatric and neurological drugmaker, and radiopharmaceutical group RayzeBio....
...US start-up Intellia Therapeutics has launched the first late-stage trial for an in-vivo Crispr treatment for a rare heart condition. The costs are also a strain for higher-income countries....
...It creates therapeutic expectations that vastly exceed the evidence base, which is strong for most mental illnesses, but weak for, let’s say, “happiness deficit disorder”....
...Charpentier formed Crispr Therapeutics, a Nasdaq-listed company, in 2013 to boost the development of gene editing to treat diseases....
...UK prime minister will take advice from chief executives of companies ranging from ScottishPower, the energy supplier, and Lloyds Banking Group, to high street food store Greggs and pharma company OMass Therapeutics...
...Novartis: shares were up 3.7 per cent after it announced a strategic partnership with Voyager Therapeutics of the US and broker Jefferies raised its target price....
...California’s Carmot Therapeutics is working on GLP-1 and other analogues that promise to be relatively well-tolerated. Roche recently agreed to buy the company for up to $3bn....
...Its share price has risen just over 5 per cent since listing.Kyverna Therapeutics, which is developing therapies to treat autoimmune diseases, provided the latest sign of investor appetite when it raised...
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Last month, Swiss pharmaceutical company Roche agreed an up to $3.1bn takeover of obesity drug developer Carmot Therapeutics....
...The group has three “blockbuster franchises” that generate more than $1bn of annual sales, and aims to add another in therapeutic dermatology....
...The US Federal Trade Commission will sue to block Amgen’s multibillion-dollar deal to acquire Horizon Therapeutics, according to a person familiar with the matter....
...Bristol Myers Squibb has agreed to buy neuroscience biotech Karuna Therapeutics for $14bn, gaining access to a promising schizophrenia drug....
From Jean-Jacques and Catherine Schul, Lasne, Belgium
International Edition